Upexi, Inc. (NASDAQ:UPXI – Get Free Report) shares rose 7.2% during trading on Wednesday . The stock traded as high as $1.21 and last traded at $1.19. Approximately 3,694,022 shares changed hands during trading, a decline of 57% from the average daily volume of 8,682,356 shares. The stock had previously closed at $1.11.
Analysts Set New Price Targets
Several research analysts have recently weighed in on UPXI shares. iA Financial set a $8.00 price target on Upexi in a research note on Tuesday, January 13th. Wall Street Zen lowered Upexi from a “hold” rating to a “sell” rating in a research report on Saturday, January 3rd. Weiss Ratings restated a “sell (d)” rating on shares of Upexi in a research note on Monday, December 29th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $2.00 price target (down from $6.00) on shares of Upexi in a report on Wednesday, February 11th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $8.33.
Get Our Latest Report on Upexi
Upexi Price Performance
Upexi (NASDAQ:UPXI – Get Free Report) last issued its quarterly earnings data on Tuesday, February 10th. The company reported ($2.94) earnings per share for the quarter, missing the consensus estimate of ($0.08) by ($2.86). Upexi had a negative return on equity of 41.47% and a negative net margin of 496.86%.The business had revenue of $10.96 million during the quarter, compared to the consensus estimate of $9.42 million.
Institutional Trading of Upexi
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Ameritas Advisory Services LLC purchased a new position in shares of Upexi during the 3rd quarter valued at about $26,000. Clearstead Advisors LLC bought a new position in shares of Upexi in the fourth quarter worth approximately $27,000. Price T Rowe Associates Inc. MD purchased a new stake in shares of Upexi in the fourth quarter worth $35,000. Belpointe Asset Management LLC purchased a new position in shares of Upexi during the 3rd quarter valued at $58,000. Finally, Arkadios Wealth Advisors bought a new position in Upexi in the 3rd quarter worth $58,000. Hedge funds and other institutional investors own 5.68% of the company’s stock.
Upexi Company Profile
Upexi (NASDAQ: UPXI) is a full-service digital consultancy that partners with brands to design, develop, and deploy digital products and marketing strategies. The company’s expertise spans user experience and interface design, custom software engineering, and data-driven marketing services. By integrating research, creative design, and technical execution, Upexi helps clients accelerate product development cycles and optimize their digital presence.
The firm serves a diverse, global clientele across sectors such as e-commerce, software-as-a-service (SaaS), healthcare, and finance.
Recommended Stories
Receive News & Ratings for Upexi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Upexi and related companies with MarketBeat.com's FREE daily email newsletter.
